Skip to main content
CVS logo

CVS · CVS HEALTH Corp · Analyst Estimates

Track CVS — free
$86.46 +1.26 (+1.48%) At close · Oct 2
Market Cap
$110.82B
Shares
1.28B
Volume · Oct 2 10.46M Avg daily vol (3M) 7.72M

Analyst Estimates

Compare analyst forecasts for CVS HEALTH Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-03 12:20 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
7.94
8.04331
8.15363
—
7.97047
7.45278
8.04331
7.43378
— — — —
EPS
analysts
Publication date not stated
— — —
25
— — — —
0
0
23
2
Revenue
USD
Publication date not stated
414205361730
418049886980
427325000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
8.43
8.53485
9.05
—
8.50713
8.42042
8.52869
8.38336
— — — —
EPS
analysts
Publication date not stated
— — —
26
— — — —
4
1
17
1
Revenue
USD
Publication date not stated
410659000000
429970940290
451274000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
22
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.46
1.62851
1.8
—
1.62837
1.71035
1.62481
1.71191
— — — —
EPS
analysts
Publication date not stated
— — —
23
— — — —
18
2
2
0
Revenue
USD
Publication date not stated
102347623380
104814184650
108936000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.15
1.26618
1.4
—
1.29427
1.32558
1.26919
1.3252
— — — —
EPS
analysts
Publication date not stated
— — —
23
— — — —
13
1
6
1
Revenue
USD
Publication date not stated
104083000000
106962997060
112187000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —
Key facts CIK 64803 CUSIP 126650100 13F (30d) 53 filings 32 filers Visit website Investor relations